Open notes sounds great, but will a provider’s documentation change? An exploratory study of the effect of open notes on oncology documentation
Maryam Rahimian(Beth Israel Deaconess Medical Center), Robin Joyce(Beth Israel Deaconess Medical Center), Roger B. Davis(Beth Israel Deaconess Medical Center), Jeremy L. Warner(Brown University), Liz Salmi(Beth Israel Deaconess Medical Center), S. Trent Rosenbloom(Vanderbilt University Medical Center)
Cited by 26
Related Papers
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
|Blood|2010|866
Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States
|Annals of Internal Medicine|2001|749